Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Speid & Associates is a private regulatory affairs and drug development consultancy serving pharmaceutical, biotechnology, and healthcare product companies. The firm provides strategic support across the development lifecycle, including regulatory strategy, IND-enabling development, clinical development planning, FDA and EMA interactions, CMC support, and commercialization-oriented market access guidance. Its capabilities span new chemical entities, biologics, 505(b)(2) applications, diagnostics, devices, injectables, and solid dosage forms. Rather than developing its own therapeutic pipeline, the company operates as a specialist advisory business led by founder and president Dr. Lorna Speid, helping sponsors advance products from early development through approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Speid & Associates.